Long-form reading · Shared publisherMeet the Long-view Desk ↗
Metabolic
Care JournalMCJ / 01

The care edit / promotional #1

CoreAge Rx

What will the care and payment arrangement look like after the first order?

Offer notes / October 5, 2026

Semaglutide from $99/month; tirzepatide from $149/month.

Looking beyond the starting amount

CoreAge Rx's product pages advertise compounded semaglutide from $99 monthly and tirzepatide from $149. The pricing help page describes one-, three-, six- and twelve-month options, with lower monthly equivalents on some longer plans. Medical review and shipping are described as included. We checked those public pages on October 5, 2026.

The calendar question

The provider distinguishes one-time purchases from optional subscriptions. A longer purchase does not automatically mean automatic renewal, and an optional subscription should not be mistaken for a single order. Put the selected term and any future charge on your calendar using the written offer, then confirm what follow-up remains available during that period.

When circumstances change

A question about tolerability or treatment suitability belongs with the clinician. A question about canceling a future payment belongs with the service's billing process. CoreAge's stated final-sale boundary follows prescription approval and transmission to the pharmacy. Clarify that point before paying; changing a treatment plan does not by itself establish a right to reverse a completed transaction.

The medical distinction

The reviewed products are compounded, not FDA-approved medicines. Ask the clinician why that preparation is proposed for your needs and request the dispensing pharmacy's identity. A convenient bundle should still leave the product and responsible professionals easy to identify.

This journal places CoreAge first for promotional reasons selected by the publisher, with possible compensation from links. We have not enrolled, tested its follow-up or measured its outcomes. The long-view question is whether the actual arrangement can be understood and maintained in your circumstances. A dated public offer is a starting point for that conversation, not the whole answer.

Source notes

Checked October 5, 2026. Provider pages document advertised terms. Study summaries identify the scope of our review.

  1. CoreAge Rx — semaglutideProvider offer
  2. CoreAge Rx — tirzepatideProvider offer
  3. CoreAge Rx — pricing and plansProvider terms
  4. FDA — compounding questions and answersRegulatory context

Return to the care comparison →